INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
![actigraph_fda]( "Addressing Opportunities And Challenges In Digital Health Data")
Addressing Opportunities And Challenges In Digital Health DataExperts from diverse industry sectors unpack key points from the FDA’s final guidance on Digital Health Technologies (DHT) for remote data collection in clinical investigations.
-
![GettyImages-1278800031 diverse trial participants]( "Completed Clinical Trials, Terminations Both Rose In 2023")
Completed Clinical Trials, Terminations Both Rose In 2023This white paper highlights how the widespread growth in completed trials is coupled with higher success rates across multiple therapeutic areas, signaling the end of pandemic-related disruptions and infectious disease-related activity after three years of fluctuations.
-
![IQVIA ecoa web thumb]( "IQVIA eCOA: Amplifying The Patient's Voice")
IQVIA eCOA: Amplifying The Patient's VoiceDive deep into the capabilities of IQVIA's eCOA with our expert Edward Bartels. He will focus on how to effortlessly create a diary, schedule site/participant assessments, and intuitively manage translations and compliance.
-
![GettyImages-635978124 research computer]( "Eliminate Clinical Trial White Space With The Right AI Strategy")
Eliminate Clinical Trial White Space With The Right AI StrategyLearn how sponsors and CROs are using agentic AI to eliminate the unproductive time caused by manual, sequential processes and fragmented data systems.
-
Pharma R&D Review 2024: Pleasant Weather Ahead5/16/2024
Gain insights from the 2024 pharma landscape, which reports a record-breaking 22,825 pipeline drugs, led by Pfizer's 32 new candidates and a strong focus on oncology and neurological treatments.
-
Accelerate Parkinson's Drug Development With Active, Passive DHT Monitoring4/15/2025
Discover how a new ActiGraph–Indivi partnership is enhancing neurology clinical trials with digital health technologies that enable more sensitive, real-world outcome measures.
-
Automation Is Key For Companies Transitioning From R&D To Clinical Trials11/14/2024
Transitioning from R&D to clinical trials is challenging, but incorporating automation can be a big step toward overcoming technology challenges, streamlining operations, and reducing error rates.
-
Choosing RTSM? Evaluate The Team Running It, Not Just The Software2/25/2026
High-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.
-
Collaborative Effort To Advance Clinical Research With DHTs6/13/2024
Discover insights from the ActiGraph Digital Data Summit (ADDS), a unique gathering uniting researchers across academia and industry to promote digital health technology in clinical research, shaping the future of healthcare.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
![GettyImages-1026593952 tablet, data]( "Proactive COA Data Quality With PureSignal Analytics")
This blinded data analytics solution helps identify and mitigate COA data quality issues before they impact signal detection — optimizing rater reliability and scoring consistency.
-
![mobile online banking and payment GettyImages-1195693419]( "Patient-Centric, Native App Helps To Streamline TrialsPatient-Centric, Native App Helps To Streamline Trials")
The myMedidata App is a patient-centric, native app designed to provide trial participants with another option for a seamless platform experience and single login for all of their remote trial activities.
-
![GettyImages-2179880251-digital-validation-hands-blue]( "Modernize Clinical Research With Continuous Digital Data")
Modernize clinical research with a unified digital platform that collects continuous, high-precision data to provide meaningful discovery in clinical trials.
-
![GettyImages-870849774 EDC medrio]( "Your Medical Imaging Workflow Solution")
By addressing common "pain points" such as the complex handling of DICOM files and unreliable transfer methods, the Judi platform prevents workflows from coming to a grinding halt.
-
![GettyImages-2032712502-scientists-tablet-training-labratory]( "Navigate The Early Phases Of Product Development With Ease")
Early Phase Experts
As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.
With a broad range of experience delivering Phase 1 Healthy Volunteer, First in Human, First in Patient and Phase 2 trials, we know just how important it is for your asset to succeed in the early development lifecycle. Our experienced team will help you obtain high-quality data that will appeal to future investors, meet the requirements of international regulatory bodies such as the FDA, EMA, PMDA, and Health Canada, and prepare your product for larger Phase 3 and 4 studies, partnerships, licensing, and sale.
Whatever your clinical trial needs, we can provide a flexible, bespoke solution that will not only meet your regulatory requirements but also position your product for commercial success.
